Unfractionated heparin dosing and risk of major bleeding in non–ST-segment elevation acute coronary syndromes

Chiara Melloni, Eric D. Peterson, E. Magnus Ohman(Tarzana Treatment Centers), Charles V. Pollack, Matthew T. Roe(Clinical Research Institute), Karen P. Alexander(Clinical Research Institute), Anita Y. Chen(University of Rochester Medicine), Nancy M. Allen LaPointe(Duke Medical Center), W. Brian Gibler(University of Cincinnati), L. Kristin Newby(Duke University)
American Heart Journal
June 3, 2008
10.1016/j.ahj.2008.03.023
Cited by 46

Related Papers

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
|Journal of the American College of Cardiology|2014|3.6k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
|Journal of the American College of Cardiology|2016|1.6k
Bivalirudin for Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2006|1.5k
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery
|Circulation|2016|1.3k